Here are five quick facts:
1. The company’s shares however, dropped 5.61 percent on a four-week basis.
2. The shares have outperformed the S&P 500 by 5.48 percent in the past week but underperformed the index by 4.62 percent in the last four weeks.
3. The company has a 52-week high of $66.30 and a 52-week low of $41.70.
4. The 50-day moving average of the shares is $62.54 and the 200-day moving average is $56.72.
5. The company has a market cap of $ $2.14 billion.
More articles on devices:
Amedica signs additional OEM letter of intent supply agreement: 5 things to know
Stryker earnings skyrocket 206%: 10 key notes on 2Q
National neurosurgery registry wins CMS PQRS approval: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
